In a recent episode of Chemo Coffee Talk, host and triple-negative breast cancer survivor Carly Fauth speaks with Dr. Jeffrey Gross, a former neurosurgeon who now focuses on regenerative and anti-aging medicine with ReCELLerbrate. The discussion offers a grounded look into how emerging therapies may assist cancer survivors beyond the traditional treatment window.
Dr. Gross introduces regenerative medicine as a strategy to activate the body’s own repair systems, particularly through the use of stem cells and natural killer (NK) cells. A significant portion of the episode centers on NK cell exosomes—tiny vesicles derived from NK cells that have shown potential in targeting cancer cells without damaging surrounding healthy tissue.
Dr. Gross notes the use of these therapies abroad and in experimental contexts, especially for addressing the side effects of chemotherapy and radiation. Importantly, he emphasizes that these approaches are meant to complement—not replace—traditional care.
The episode touches on patient accessibility, safety profiles, and how such strategies could aid in remission maintenance or long-term healing. Dr. Gross and Fauth also reflect on how these emerging therapies may help patients regain quality of life, especially after aggressive treatments.
This conversation is not about hype, but aactually cautious optimism. It reflects the growing interest in regenerative recovery methods and highlights the importance of continued research into post-treatment support for cancer patients.
